Cytomegalovirus infection rate among heart transplant patients in relation to the potency of antithymocyte immunoglobulin induction therapy. Copenhagen Heart Transplant Group

Transplant Proc. 1994 Jun;26(3):1718.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Antilymphocyte Serum / adverse effects*
  • Bacteremia / epidemiology
  • Cytomegalovirus Infections / epidemiology*
  • Cytomegalovirus Infections / mortality
  • Dose-Response Relationship, Drug
  • Female
  • Heart Transplantation / immunology*
  • Heart Transplantation / mortality
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications / epidemiology
  • Postoperative Complications / microbiology*
  • Retrospective Studies

Substances

  • Antilymphocyte Serum